Assyro AI

Orange Book product · Generic (ANDA)

CLINDAMYCIN PHOSPHATE AND TRETINOIN

CLINDAMYCIN PHOSPHATE; TRETINOIN

Generic (ANDA)ANDA 202564TE AB1RX ACTAVIS MID ATLANTIC

At a glance

Jun 12, 2015

Approved

Generic (ANDA)

Application

AB1

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 12, 2015

    11 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CLINDAMYCIN PHOSPHATE; TRETINOIN

Strength

1.2%;0.025%

Dosage form

GEL

Route

TOPICAL

TE code

AB1

Application

ANDA 202564

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CLINDAMYCIN PHOSPHATE; TRETINOIN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.